Invasive Breast Carcinoma Not Yet Recruiting Phase 1 Trials for Anastrozole (DB01217)

Also known as: Invasive carcinoma of breast / Breast cancer invasive NOS

Indication	Status	Phase
DBCOND0031787 (Invasive Breast Carcinoma)	Not Yet Recruiting	1

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT03554044	Talimogene Laherparepvec With Paclitaxel or Endocrine Therapy in Treating Participants With Metastatic, Unresectable, or Recurrent HER2- Negative Breast Cancer	Treatment	Anastrozole (DB01217) Exemestane (DB00990) Fulvestrant (DB00947) Letrozole (DB01006) Paclitaxel (DB01229) Talimogene laherparepvec (DB13896) Tamoxifen (DB00675)